Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000011.xml
Dtsch Med Wochenschr 2007; 132(25/26): 1373-1375
DOI: 10.1055/s-2007-982037
DOI: 10.1055/s-2007-982037
Klinischer Fortschritt | Commentary
© Georg Thieme Verlag KG Stuttgart · New York
Nephrologie 2007
Nephrology 2007Further Information
Publication History
eingereicht: 21.5.2007
akzeptiert: 24.5.2007
Publication Date:
15 June 2007 (online)
Was ist neu?
-
Zystennieren: Endlich Therapiemöglichkeiten?
-
Nephrogene systemische Fibrose: Zusammenhang mit Gadolinium?
Literatur
- 1 Biance S, Bigazzi R, Campese V M. Long term effects of spironolacton on proteinuria and kidney function in patients with chronic kidney disease. Kidney Int. 2006; 70 2116-2123
- 2 Bukanov N O et al. Long lasting arrest of murine cystic kidney disease with CDK inhibitor roscoviten. Nature. 2006; 444 949-952
- 3 Drueke T B, Locatelli F, Clyne N. et al . Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med. 2006; 355 2071-2084
- 4 Epstein M, Williams G H. et al . Selective aldosteron blockade with eplerenone reduces albuminuria in patients with Type 2 diabetes. Clin J Am Soc Nephrol. 2006; 1 940-951
- 5 Grobner T. Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?. Nephrol Dial Transplant. 2006; 21 1104-1108
- 6 Hoste E A, Clermont G. et al . RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care. 2006; 10 R73
- 7 Liu K D, Himmelfarb J, Paganini E. et al . Timing of initiation of dialysis in critically ill patients with acute kidney injury. Clin J Soc Am Nephrol. 2006; 1 915-919
- 8 Marckmann P, Skov L, Rossen K. et al . Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol. 2006; 17 2359-2362
- 9 Marenzi G, Assanelli F, Marana I. et al . N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med. 2006; 354 2773-2782
- 10 Rocco M V, Frankenfield D L, Hopson S D, McClellan W M. Relationship between clinical performance measures and outcomes among patients receiving long term hemodialysis. Ann Int Med. 2006; 145 512-519
- 11 Singh A K, Szczech L, Tang K L. et al . Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med. 2006; 355 2085-2098
- 12 Uchino S. et al . An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit Care Med. 2006; 34 1913-1917
- 13 Vinsonneau C, Camus C. et al . Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome. Lancet. 2006; 368 379-385
- 14 Wattanakit K, Coresh . et al . Cardiovascular risk among adults with chronic kidney disease, with or without prior myocardial infarction. J Am Coll Cardiol. 2006; 48 1183-1189
- 15 Wattanakit K. et al . Kidney function and risk of peripheral arterial disease: Results from the atherosclerosis risk in community (ARIC) studies. J Am Soc Nephrol. 2007; 18 629-636
Prof. Dr. med. Christian Hugo
Medizinische Klinik 4, Universität Erlangen-Nürnberg
Krankenhausstraße 12
91054 Erlangen
Phone: 09131/8536028
Fax: 09131/8539209
Email: christian.hugo@rzmail.uni-erlangen.de